Latest From USV Ltd.
Natco has sprung a challenge to Novartis’ vildagliptin patent in India, months before its expiry. The Indian firm will hold back further release of its product on the market amid legal action and it remains to be seen if Novartis will pursue damages.
Juta Pharma has received a positive opinion from the European Medicines Agency’s CHMP recommending granting a pan-European marketing authorization for its biosimilar pegfilgrastim, Grasustek.
Two biosimilar versions of Amgen’s blockbuster drug, Neulasta, are up for an opinion from the European Medicines Agency this week on whether they should be approved in the EU. Coherus is the sponsor of one of the products.
- Therapeutic Areas
- Parent & Subsidiaries
- USV Ltd.
- Senior Management
Prashant Tewari, Managing Dir.
Debabrata Gupta, COO
- Contact Info
Arvind Vithal Gandhi Chowk, Station Rd.
Mumbai, 400 088
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.